WARF: P07080US

  • Assigned to WARF as biological material.

Exploring Natural Products from Actinobacteria Symbionts Associated with Animals and Plants


Cameron Currie

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing a collection of more than 150 unique strains of actinomycetes.
OVERVIEWActinomycetes, which are Gram-positive filamentous bacteria, produce the majority of known antibiotics. Fungus-growing Attine ants engage in a mutualistic association with actinomycetes to defend their fungus garden. Other animals and plants also have symbiotic associations with actinomycetes.
THE INVENTIONA UW-Madison researcher has collected more than 150 unique strains of actinomycetes obtained from ants, bees, lichens, bark beetles and other macroorganisms. DNA sequencing has confirmed that these strains are novel, and thus have not been previously screened. Bioassays revealed the in vitro production of antifungal and antibacterial compounds by many of these strains.
  • May enable the development of new antibacterial and antifungal compounds
  • Provides a novel, potent and diverse collection of actinomycetes for new antibiotics or other natural products
For More Information About the Inventors
Contact Information
For current licensing status, please contact Mark Staudt at or 608-960-9845.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.